Analyst picks & changes

Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass.

Business: Gene/Cell therapy

Montgomery Securities analyst David Crossen

Read the full 143 word article

How to gain access

Continue reading with a
two-week free trial.